diseases of larynx
Conditions
Interventions
Experimental group :Ketamine 0.5mg/kg
control group:Equal volume physiological saline
Sponsors
Shanghai Changhai Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: 1. Age: 18~64 years old 2. BMI: 18-30kg/m2 3. ASA Level I or II 4. Patients undergoing supportive laryngoscopy surgery under elective general anesthesia 5. The patient voluntarily participates and signs an informed consent form
Exclusion criteria
Exclusion criteria: 1. Allergic to ketamine 2. Patients who are pregnant or breastfeeding 3. History of severe hypertension and heart disease 4. History of chronic obstructive diseases and asthma 5. Severe liver and kidney dysfunction 6. History of psychiatric disorders 7. Hyperthyroidism patients 8. Patients with increased intracranial pressure and intraocular pressure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Whether it can reduce the incidence of cardiovascular adverse events ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Whether it can improve the quality of awakening and alleviate postoperative pain for patients; | — |
Countries
CHINA
Contacts
Public Contactwang hengyue
Shanghai Changhai Hospital
Outcome results
None listed